0001145549-19-050460.txt : 20191210 0001145549-19-050460.hdr.sgml : 20191210 20191210075227 ACCESSION NUMBER: 0001145549-19-050460 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191210 DATE AS OF CHANGE: 20191210 EFFECTIVENESS DATE: 20191210 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ELLSWORTH GROWTH & INCOME FUND LTD CENTRAL INDEX KEY: 0000793040 IRS NUMBER: 133345139 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-04656 FILM NUMBER: 191276543 BUSINESS ADDRESS: STREET 1: 65 MADISON AVENUE STREET 2: SUITE 550 CITY: MORRISTOWN STATE: NJ ZIP: 07960 BUSINESS PHONE: (973) 631-1177 MAIL ADDRESS: STREET 1: 65 MADISON AVE STREET 2: SUITE 550 CITY: MORRISTOWN STATE: NJ ZIP: 07960 FORMER COMPANY: FORMER CONFORMED NAME: ELLSWORTH FUND LTD DATE OF NAME CHANGE: 20060330 FORMER COMPANY: FORMER CONFORMED NAME: ELLSWORTH CONVERTIBLE GROWTH & INCOME FUND INC DATE OF NAME CHANGE: 19920703 N-CEN 1 primary_doc.xml X0201 N-CEN LIVE 0000793040 XXXXXXXX false false false N-2 Ellsworth Growth & Income Fund Ltd 811-04656 0000793040 549300GYFOXHCDQTI772 One Corporate Center Rye 10580-1422 US-NY US 1-800-422-3554 The Bank of New York Mellon 240 Greenwich Street New York 10286 212-495-1784 Accounting BNY Mellon Investment Servicing (US) Inc. 301 Bellevue Parkway Wilmington 19809 302-791-1700 Accounting State Street Bank and Trust Company One Heritage Drive North Quincy 02171 617-786-3000 Custody Gabelli Funds, LLC One Corporate Center Rye 10580-1422 914-921-5100 Accounting American Stock Transfer & Trust Company, LLC 15th Avenue 6201 Brooklyn 11219 800-937-5449 Transfer Agent N N N-2 Y James P. Conn N/A N James A. Dinsmore N/A Y Kinchen C. Bizzell N/A N Daniel D. Harding N/A N Nicolas W. Platt N/A N Michael J. Melarkey N/A N Kuni Nakamura N/A N Mario J. Gabelli 000216136 Y Frank J. Fahrenkopf, Jr. N/A N Elizabeth C. Bogan N/A N Anthonie C. van Ekris N/A N Richard J. Walz 001392836 One Corporate Center Rye 10580 XXXXXX N N N N N N N PricewaterhouseCoopers LLP 238 5493002GVO7EO8RNNS37 N N N N N Ellsworth Growth & Income Fund Ltd 549300GYFOXHCDQTI772 N 0 0 0 N/A N N Y N N/A N/A N/A Rule 17e-1 (17 CFR 270.17e-1) N N N N Gabelli Funds, LLC 801-37706 000104949 549300JDTNRQK8NMTG03 N American Stock Transfer & Trust Company, LLC 084-00416 254900TS5EWP83BEOU02 N N N Intercontinental Exchange, Inc. 5493000F4ZO33MV32P92 N Bloomberg Finance L.P. 5493001KJTIIGC8Y1R12 N N State Street Bank and Trust Company 571474TGEMMWANRLN572 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N American Stock Transfer & Trust Company, LLC 254900TS5EWP83BEOU02 N N N BNY Mellon Investment Servicing (US) Inc. 549300CFZQLI9QMJ1Z03 N Y Gabelli Funds, LLC 549300JDTNRQK8NMTG03 Y N N G.Research, LLC 008-21373 000007353 N/A 1300.000000000000 G.distributors, LLC 008-68697 000155071 N/A 0.000000000000 G.RESEARCH, LLC 008-21373 000007353 N/A 1300.000000000000 GOLDMAN SACHS & CO. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 600.000000000000 Cowen and Company, LLC 008-22522 000007616 549300WR155U7DVMIW58 3831.000000000000 5731.000000000000 BARCLAYS CAPITAL, INC. 008-41342 000019714 AC28XWWI3WIBK2824319 34761346.000000000000 BOFA SECURITIES, INC. 008-69787 000283942 549300HN4UKV1E2R3U73 8309638.000000000000 MUFG SECURITIES AMERICAS INC. 008-43026 000019685 K5HU16E3LMSVCCJJJ255 5828214.000000000000 Goldman Sachs & Co. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 9151906.000000000000 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 11464079.000000000000 RAYMOND JAMES & ASSOCIATES, INC. 008-10999 000000705 U4ONQX15J3RO8XCKE979 7636859.000000000000 OPPENHEIMER & CO. INC. 008-04077 000000249 254900VH02JQR2L8XD64 23900947.000000000000 NOMURA SECURITIES INTERNATIONAL, INC. 008-15255 000004297 OXTKY6Q8X53C9ILVV871 50494997.000000000000 CREDIT SUISSE SECURITIES (USA) LLC 008-00422 000000816 1V8Y6QCX6YMJ2OELII46 7546763.000000000000 BMO CAPITAL MARKETS CORP. 008-34344 000016686 RUC0QBLBRPRCU4W1NE59 11945660.000000000000 201854123.000000000000 Y 171971164.000000000000 0.000000000000 Common stock C000000000 Preferred stock 5.25% Series A Cumulative Preferred Shares N N N N N N 0.800000000000 1.200000000000 10.490000000000 11.420000000000 true INTERNAL CONTROL RPT 2 internalcontrolrpt_ellsworth.htm

Report of Independent Registered Public Accounting Firm

To the Board of Trustees and Shareholders of Ellsworth Growth and Income Fund Ltd.

In planning and performing our audit of the financial statements of Ellsworth Growth and Income Fund Ltd. (the “Fund”) as of and for the year ended September 30, 2019, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund’s internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund’s internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund’s internal control over financial reporting.

The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A fund’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A fund’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the fund; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the fund are being made only in accordance with authorizations of management and directors of the fund; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a fund’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the fund’s annual or interim financial statements will not be prevented or detected on a timely basis.

Our consideration of the Fund’s internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund’s internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be material weaknesses as defined above as of September 30, 2019.

This report is intended solely for the information and use of the Board of Trustees of Ellsworth Growth and Income Fund Ltd. and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties.

/s/ PricewaterhouseCoopers LLP

New York, New York

November 26, 2019